Cognitive Conditions Fueling Demand For Dietary Ingredient Breakthroughs

Rising rates of Alzheimer’s disease and other cognitive conditions fuel demand for brain health supplements among consumers, with more than a third of US consumers saying they would be “very likely” to take them for memory, according to research firm Natural Marketing Institute.

Research on cognitive-boosting dietary ingredients could produce breakthroughs in 2019 as rising rates of Alzheimer’s disease and dementia fuel consumer interest in supplements promoted to enhance memory and drive R&D investment, says market research firm Natural Marketing Institute, Inc.

Omega-3s represent the biggest potential but B vitamins and ginkgo biloba also are being assessed for improving memory, alertness or...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

Over The Counter: Seizing The GLP-1 Wellness Opportunity, With Kerry Group’s Mathieu Millette

 
• By 

HBW Insight speaks to Kerry Group's RDA director for digestive health, Mathieu Millette, about the opportunity represented by the global trend for GLP-1 agonists for consumer health.

Consumers More Often Choosing Private Label First

 

First Insight report from survey conducted in April with 1,267 US consumers notes that the Private Label Manufacturers Association recorded private label sales increasing by nearly 4% in 2024 to a record $271bn.

People In US Consumer Health News: Bayer North America Treasurer Takes On CFO Role, Too

 

Bayer North America CFO with firm since 2008; Cosette VP for quality, regulatory affairs; FDA labeling review official joins ProPharma; Lifecykel, UFC veterans launch Mongolian training camp; and Beverly Hills surgeons offer skin care supplement.

OLLY’s Lovin’ Libido Claims Score Support With Studies Of Women Reporting ‘Generally Low’ Desire

 

NAD reports the populations of six of seven RCTs Olly referenced as evidence were key in substantiating claims for Lovin’ Libido ashwagandha supplement challenged by Bayer. Supplement industry, though, is challenging the FTC’s RCT standard for claims support.

More from Wellness

OLLY’s Lovin’ Libido Claims Score Support With Studies Of Women Reporting ‘Generally Low’ Desire

 

NAD reports the populations of six of seven RCTs Olly referenced as evidence were key in substantiating claims for Lovin’ Libido ashwagandha supplement challenged by Bayer. Supplement industry, though, is challenging the FTC’s RCT standard for claims support.

Cloudy Tariff Conditions Expected To Linger In US

 

White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.

US FDA’s Tough Talk On Talc: Regulating In An Echo Chamber

 

An FDA “expert roundtable” on talc produced a new talking point on a potential drug safety risk, but the basis of that claim is difficult to determine.